Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Hedner

Showing results (201-210 of 242) with videos related to

Pageof 25
Sort By:
Blood|July 1, 1992
Measurement of basal levels of factor VIIa in hemophilia A and B patientsP Wildgoose, Y Nemerson, L L Hansen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 10, 2006
Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surfaceS Ghosh, M Ezban, E Persson, et al.
Blood|March 21, 1998
Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coliF B Taylor, A C Chang, G Peer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1991
No transplacental passage of standard heparin or an enzymatically depolymerized low molecular weight heparinT Mätzsch, D Bergqvist, A Bergqvist, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2000
Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding riskM L Manzano, C Arocena, J F Tomás, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1994
Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin). An experimental investigation in healthy volunteersJ Holst, B Lindblad, D Bergqvist, et al.
FEBS Letters|July 20, 1992
Generation of Gla-domainless FVIIa by cathepsin G-mediated cleavageE M Nicolaisen, L C Petersen, L Thim, et al.
Thrombosis Research|December 1, 1993
Tissue factor pathway inhibitor (TFPI) and its response to heparin in patients with spontaneous deep vein thrombosisJ Holst, B Lindblad, E Wedeberg, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1975
Intravascular coagulation in pregnancy--treatment with heparinI M Nilsson, U Hedner, B Astedt, et al.
Lancet (London, England)|November 19, 1988
Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomyU Hedner, S Glazer, K Pingel, et al.
Pageof 25

Showing results (201-210 of 242) with videos related to

Sort By:
Pageof 25
Blood|July 1, 1992
Measurement of basal levels of factor VIIa in hemophilia A and B patientsP Wildgoose, Y Nemerson, L L Hansen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 10, 2006
Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surfaceS Ghosh, M Ezban, E Persson, et al.
Blood|March 21, 1998
Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coliF B Taylor, A C Chang, G Peer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1991
No transplacental passage of standard heparin or an enzymatically depolymerized low molecular weight heparinT Mätzsch, D Bergqvist, A Bergqvist, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2000
Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding riskM L Manzano, C Arocena, J F Tomás, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1994
Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin). An experimental investigation in healthy volunteersJ Holst, B Lindblad, D Bergqvist, et al.
FEBS Letters|July 20, 1992
Generation of Gla-domainless FVIIa by cathepsin G-mediated cleavageE M Nicolaisen, L C Petersen, L Thim, et al.
Thrombosis Research|December 1, 1993
Tissue factor pathway inhibitor (TFPI) and its response to heparin in patients with spontaneous deep vein thrombosisJ Holst, B Lindblad, E Wedeberg, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1975
Intravascular coagulation in pregnancy--treatment with heparinI M Nilsson, U Hedner, B Astedt, et al.
Lancet (London, England)|November 19, 1988
Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomyU Hedner, S Glazer, K Pingel, et al.
Pageof 25